{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:42Z","timestamp":1790484342985,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3354,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1038\/sj.ki.5001788","type":"journal-article","created":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T14:27:35Z","timestamp":1156948055000},"page":"1486-1494","source":"Crossref","is-referenced-by-count":158,"title":["Post-transplant hypophosphatemia: Tertiary \u2018Hyper-Phosphatoninism\u2019?"],"prefix":"10.1016","volume":"70","author":[{"given":"I.","family":"Bhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Isakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-A.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"J\u00fcppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5001788_bb0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0272-6386(99)70045-4","article-title":"Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid\/base homeostasis","volume":"34","author":"Ambuhl","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001788_bb0015","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1046\/j.1523-1755.2001.00755.x","article-title":"Post-transplant hypophosphatemia","volume":"59","author":"Levi","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001788_bb0020","first-page":"333","article-title":"Hypophosphatemia in long-term renal transplant recipients: effects on bone histology and 1,25-dihydroxycholecalciferol","volume":"12","author":"Felsenfeld","year":"1986","journal-title":"Min Electrol Metabol"},{"key":"10.1038\/sj.ki.5001788_bb0025","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1046\/j.1523-1755.2001.0600031182.x","article-title":"Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia","volume":"60","author":"Green","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001788_bb0030","first-page":"356","article-title":"Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure","volume":"12","author":"Parfitt","year":"1986","journal-title":"Min Electrol Metabol"},{"key":"10.1038\/sj.ki.5001788_bb0035","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ki.1981.54","article-title":"Decreased phosphate reabsorption after renal transplantation: evidence for a mechanism independent of calcium and parathyroid hormone","volume":"19","author":"Rosenbaum","year":"1981","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001788_bb0040","first-page":"624","article-title":"Handling of phosphate by the transplanted kidney","volume":"16","author":"Graf","year":"1979","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"10.1038\/sj.ki.5001788_bb0045","first-page":"332","article-title":"Serum levels of 1,25-dihydroxyvitamin D after renal transplantation","volume":"14","author":"Riancho","year":"1988","journal-title":"Min Electrol Metabol"},{"key":"10.1038\/sj.ki.5001788_bb0050","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00007890-199310000-00013","article-title":"Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1,25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients","volume":"56","author":"Steiner","year":"1993","journal-title":"Transplantation"},{"key":"10.1038\/sj.ki.5001788_bb0055","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s002689900446","article-title":"Prospective study of calcium homeostasis after renal transplantation","volume":"22","author":"Claesson","year":"1998","journal-title":"World J Surg"},{"key":"10.1038\/sj.ki.5001788_bb0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1038\/sj.ki.5001788_bb0065","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5001788_bb0070","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5001788_bb0075","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.M210490200","article-title":"The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency","volume":"278","author":"Bai","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5001788_bb0080","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001788_bb0085","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5001788_bb0090","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001788_bb0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00774-004-0589-9","article-title":"The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome","volume":"23","author":"Yamamoto","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1038\/sj.ki.5001788_bb0100","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001788_bb0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu T","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001788_bb0110","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001788_bb0115","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1038\/sj.ki.5001788_bb0120","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2004-2364","article-title":"Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy","volume":"90","author":"Holick","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001788_bb0125","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5001788_bb0130","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23","volume":"60","author":"White","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001788_bb0135","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"FGF-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001788_bb0140","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1210\/jc.2005-1606","article-title":"Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak","volume":"91","author":"Rendina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001788_bb0145","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1523-1755.2004.00604.x","article-title":"FGF-23 in patients with end-stage renal disease on hemodialysis","volume":"65","author":"Imanishi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001788_bb0150","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00016.2003","article-title":"FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization","volume":"285","author":"Quarles","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 91","key":"10.1038\/sj.ki.5001788_bb0155","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1523-1755.2004.09102.x","article-title":"Novel aspects in regulated expression of the renal type IIA Na\/Pi-cotransporter","volume":"66","author":"Bacic D","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001788_bb0160","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1074\/jbc.M207872200","article-title":"Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production","volume":"278","author":"Saito","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5001788_bb0165","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1a,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5001788_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/sj.ki.5001788_bb0175","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5001788_bb0180","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00007890-199810150-00002","article-title":"Prolongation of allograft survival by 1,25-dihydroxyvitamin D3","volume":"66","author":"Hullett","year":"1998","journal-title":"Transplantation"},{"key":"10.1038\/sj.ki.5001788_bb0185","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.transproceed.2003.10.014","article-title":"Influence of 1,25-dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients: a retrospective cohort study","volume":"35","author":"Tanaci","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1038\/sj.ki.5001788_bb0190","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/jc.2004-0357","article-title":"Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors","volume":"90","author":"Carpenter","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001788_bb0195","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001788_bb0200","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2003.00915.x","article-title":"Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis","volume":"63","author":"Salusky","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001788_bb0205","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/ajkd.2002.34519","article-title":"PTH 1\u201384 and PTH \u20187\u201384\u2019 in the noninvasive diagnosis of renal bone disease","volume":"40","author":"Coen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001788_bb0210","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001788_bb0215","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001788_bb0220","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5001788_bb0225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","article-title":"Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD","volume":"47","author":"Coyne","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001788_bb0230","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0041-1345(03)00765-6","article-title":"Tacrolimus decreases tubular phosphate wasting in renal allograft recipients","volume":"35","author":"Falkiewicz","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1038\/sj.ki.5001788_bb0235","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V991560","article-title":"Renal Na\/H exchanger NHE-3 and Na-PO4 cotransporter NaPi-2 protein expression in glucocorticoid excess and deficient states","volume":"9","author":"Loffing","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001788_bb0240","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00042737-200012080-00013","article-title":"Incidence of vertebral fractures in the first three months after orthotopic liver transplantation","volume":"12","author":"Ninkovic","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1038\/sj.ki.5001788_bb0245","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001788_bb0250","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","article-title":"Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells","volume":"288","author":"Ito","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001788_bb0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5001788_bb0260","series-title":"Applied Regression Analysis and Other Multivariable Methods","author":"Kleinbaum","year":"1998"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815521650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815521650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:44:25Z","timestamp":1627778665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815521650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0085253815521650"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5001788","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}